Expedited Review claims are paid the current Payment Percentage of the Scheduled Value for each disease as outlined in the TDP. Expedited Review is also intended to provide qualifying claimants a fixed and certain claim payment.  The current Payment Percentage is 60%.

Halliburton or Non-Harbison-Walker Entity Claims

Disease LevelScheduled Value
Mesothelioma  (Level VIII)
$59,522.55
Lung Cancer 1 (Level VII)
$9,677.62
Other Cancer  (Level V)
$8,324.83
Severe Asbestosis  (Level IV)
$9,781.68
Asbestosis/Pleural Disease (Level III)
$2,497.45
Asbestosis/Pleural Disease (Level II)
$1,144.66
Other Asbestos Disease (Level I)
$104.06

 

Harbison-Walker Entity Claims

Disease LevelScheduled Value
Mesothelioma (Level VIII)
$142,042.45
Lung Cancer 1 (Level VII)
$46,723.12
Other Cancer (Level V)
$24,974.50
Severe Asbestosis (Level IV)
$30,697.82
Asbestosis/Pleural Disease (Level III)
$7,492.35
Asbestosis/Pleural Disease (Level II)
$3,954.30
Other Asbestos Disease (Level I)
$312.18